Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.0
Journals
JCM
Special Issues
Utilizing Technology Solutions and Novel Medications in the Prevention, Diagnosis,...
jcm-logo
Submit to JCM Review for JCM Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Utilizing Technology Solutions and Novel Medications in the Prevention, Diagnosis, and Management of Diabetes Mellitus

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Endocrinology & Metabolism".

Deadline for manuscript submissions: closed (20 October 2024) | Viewed by 1943

Special Issue Editors

Dr. Elias K. Spanakis

E-Mail Website
Guest Editor
Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA
Interests: inpatient management of diabetes; hyperglycemia; hypoglycemia; continuous glucose monitoring (CGM) devices
Dr. Eileen R. Faulds

E-Mail Website
Guest Editor
Division of Endocrinology, Diabetes & Metabolism, The Ohio State University College of Medicine, Columbus, OH, USA
Interests: diabetes complications; diabetes mellitus type 1; diabetes mellitus type 2; blood glucose self-monitoring
Dr. Alexandra L. Migdal

E-Mail Website
Guest Editor
Division of Endocrinology, Emory University, Atlanta, GA, USA
Interests: diabetic ketoacidosis; low blood sugar; pseudohypoparathyroidism; thyroid nodule; type 2 diabetes (t2d)

Special Issue Information

Dear Colleagues,

The prevalence of diabetes mellitus (DM) is rising globally, currently affecting more than 422 million people worldwide. The consequences of DM include macro-vascular and micro-vascular complications, which contribute to increased morbidity, mortality, and higher hospital costs. In this Special Issue of the Journal of Clinical Medicine, we aim to collate research papers that expand our knowledge on the use of technology and novel medications for the prevention, diagnosis, and management of DM. We welcome submissions of clinical intervention studies, observational real-world studies and metanalyses, as well as studies reporting patients’ outcomes.

We look forward to your submissions.

Dr. Elias K. Spanakis
Dr. Eileen R. Faulds
Dr. Alexandra L. Migdal
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • diabetes mellitus
  • continuous glucose monitoring
  • diabetes management
  • technology solutions

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

11 pages, 248 KiB  
Article
Effect of Body Weight on Glycaemic Indices in People with Type 1 Diabetes Using Continuous Glucose Monitoring
by Maria A. Christou, Panagiota A. Christou, Daphne N. Katsarou, Eleni I. Georga, Christos Kyriakopoulos, Georgios Markozannes, Georgios A. Christou, Dimitrios I. Fotiadis and Stelios Tigas
J. Clin. Med. 2024, 13(17), 5303; https://doi.org/10.3390/jcm13175303 - 7 Sep 2024
Cited by 1 | Viewed by 1432
Abstract
Background/Objectives: Obesity and overweight have become increasingly prevalent in different populations of people with type 1 diabetes (PwT1D). This study aimed to assess the effect of body weight on glycaemic indices in PwT1D. Methods: Adult PwT1D using continuous glucose monitoring (CGM) [...] Read more.
Background/Objectives: Obesity and overweight have become increasingly prevalent in different populations of people with type 1 diabetes (PwT1D). This study aimed to assess the effect of body weight on glycaemic indices in PwT1D. Methods: Adult PwT1D using continuous glucose monitoring (CGM) and followed up at a regional academic diabetes centre were included. Body weight, body mass index (BMI), waist circumference, glycated haemoglobin (HbA1c), and standard CGM glycaemic indices were recorded. Glycaemic indices were compared according to BMI, and correlation and linear regression analysis were performed to estimate the association between measures of adiposity and glycaemic indices. Results: A total of 73 PwT1D were included (48% normal weight, 33% overweight, and 19% obese). HbA1c was 7.2% (5.6–10), glucose management indicator (GMI) 6.9% (5.7–8.9), coefficient of variation (CV) for glucose 39.5% ± 6.4, mean glucose 148 (101–235) mg/dL, TIR (time in range, glucose 70–180 mg/dL) 66% (25–94), TBR70 (time below range, 54–69 mg/dL) 4% (0–16), TBR54 (<54 mg/dL) 1% (0–11), TAR180 (time above range, 181–250 mg/dL) 20% ± 7, and TAR250 (>250 mg/dL) 6% (0–40). Glycaemic indices and achievement (%) of optimal glycaemic targets were similar between normal weight, overweight, and obese patients. BMI was associated negatively with GMI, mean glucose, TAR180, and TAR250 and positively with TIR; waist circumference was negatively associated with TAR250. Conclusions: CGM-derived glycaemic indices were similar in overweight/obese and normal weight PwT1D. Body weight and BMI were positively associated with better glycaemic control. PwT1D should receive appropriate ongoing support to achieve optimal glycaemic targets whilst maintaining a healthy body weight. Full article
(This article belongs to the Special Issue Utilizing Technology Solutions and Novel Medications in the Prevention, Diagnosis, and Management of Diabetes Mellitus)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop